Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.
Press releases published on September 29, 2025
September 29, 2025
Plant Parenting Emerges as 2025’s Wellness Trend: Stress Relief, Cleaner Air, and Focus Gains
Indeterminate
EIN Presswire
September 29, 2025
Wellbridge Highlights Need for Specialized Addiction Treatment for First Responders
Indeterminate
EIN Presswire
September 29, 2025
Wellbridge Drug & Alcohol Rehab Highlights the Importance of Aftercare in Sustaining Recovery
Indeterminate
EIN Presswire
September 29, 2025
Wellbridge Long Island Rehab Emphasizes Specialized Care for Healthcare Professionals
Indeterminate
EIN Presswire
September 29, 2025
Digitas Health Names Widerson Souza and Thiago Fernandes Deputy Chief Creative Officers
Indeterminate
EIN Presswire
September 29, 2025
Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases
Indeterminate
GlobeNewswire
September 29, 2025
Artelo Biosciences Announces Proposed Underwritten Public Offering
Indeterminate
GlobeNewswire
September 29, 2025
NANOBIOTIX annonce de nouveaux résultats de Phase 1 qui continuent de confirmer le potentiel de JNJ-1900 (NBTXR3), avec un anti-PD-1, en tant que potentielle nouvelle option thérapeutique de première ou deuxième ligne ou plus dans le CETEC R/M naïf ou …
Indeterminate
GlobeNewswire
September 29, 2025
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements
Indeterminate
GlobeNewswire
September 29, 2025
INVO Fertility to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Indeterminate
GlobeNewswire
September 29, 2025
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
Indeterminate
GlobeNewswire
September 29, 2025
Neuphoria Provides Fiscal Year-End 2025 Financial Results and Business Updates
Indeterminate
GlobeNewswire
September 29, 2025
MAIA Biotechnology Announces $2.25 Million Private Placement
Indeterminate
GlobeNewswire
September 29, 2025
Precision Optics Reports Fourth Quarter and Fiscal Year 2025 Financial Results
Indeterminate
GlobeNewswire
September 29, 2025
Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Indeterminate
GlobeNewswire
September 29, 2025
Anaptys Announces Intent to Separate Biopharma Operations from Substantial Royalty Assets by Year-end 2026
Indeterminate
GlobeNewswire
September 29, 2025
Anaptys to Provide Overview of ANB033, a CD122 antagonist, at Virtual Investor Event on Tuesday, Oct. 14
Indeterminate
GlobeNewswire